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Noninvasive brain stimulation (NIBS) techniques including transcranial magnetic stimulation
(TMS) and transcranial direct current stimulation (tDCS) are emerging as neuroscientific
techniques that can be used as in vivo probes of brain function as well as therapeutic tools in a
number of psychiatric and neurological disorders. Though much of the research and applications
with these techniques have been applied to adult psychiatry and neurology, recent years have seen
a number of researchers applying these tools to study brain development in typically developing
children as well as those with neurodevelopmental and child psychiatric and neurological disorders.
Clinical trials and case series designs have also been used to develop novel therapeutic interventions
using these NIBS techniques in pediatric clinical populations and researchers are forming working
groups dedicated to the application of NIBS to specific neurodevelopmental disorders (e.g., Autism
Spectrum Disorder, Oberman et al., 2014a).
The papers in this research topic highlight the excitement in the field and the promise of
these techniques both for the understanding of neurodevelopment (Pedapati et al., 2015) and
neuropathology of neurodevelopmental disorders (Croarkin et al., 2014; Oberman et al., 2014b)
as well as novel treatment development for neurodevelopmental disorders (Casanova et al., 2014;
Gillick et al., 2014). This excitement and promise, however, is appropriately tempered by other
papers in this research topic that highlight the unknown risks and potential ethical concerns related
to applying these techniques in pediatric populations (Davis, 2014; Maslen et al., 2014).
A recent metaanalysis (Rajapakse and Kirton, 2013) reviewed the studies to date involving
all rTMS protocols in children (approximately 1000 children have been studied across all
rTMS protocols to date) and concluded “Its minimal risk, excellent tolerability and increasingly
sophisticated ability to interrogate neurophysiology and plasticity make it an enviable technology
for use in pediatric research with future extension into therapeutic trials.” This was supported by
a paper in this topic highlighting the safety and tolerability of a specific paradigm, Theta Burst
stimulation (Hong et al., 2015).
The most serious possible TMS-related adverse event is induction of a seizure. To date, 16 cases
of TMS-induced seizures have been reported out of tens of thousands of examined subjects over the
past 25 years. Overall the risk of seizure is considered to be less than 0.01% across all patients and
all paradigms (Rossi et al., 2009). The risk of overall adverse event burden from TMS, however, may
be underestimated due to the lack of systematic identification, tracking, and reporting of adverse
events in study publications. Thus, the safety, tolerability, and efficacy have not been characterized
sufficiently to justify off-label clinical use of NIBS, especially in pediatric populations. At this point,
use of these technologies either for investigational or clinical use should be under the context of an
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investigational device exemption (IDE) or IRB approved research
trial. Unfortunately, there have been instances of “do-it-yourself ”
brain stimulation devices entering the marketplace, raising the
possibility that these techniques will be applied to individuals
with neurodevelopmental disorders without an evidence-base,
regulatory oversight, or appropriate expertise.
Despite the therapeutic promise of repetitive TMS for
neurodevelopmental disorders, translation to “treatment-
based” protocols poses a number of important challenges and
complexities. For instance, there are various considerations in
selecting pulse sequences (e.g., frequency, intensity), regions of
stimulation, and coil type, each combination of which is likely
to have different efficacy and side-effect profiles. While TMS has
been the primary technique employed in neurodevelopment thus
far, electrical stimulation techniques (e.g., tDCS, transcranial
alternating current stimulation [tACS]) have very different
mechanisms of action and risk profiles (e.g., seizure induction
is not generally indicated in tDCS/tACS). Brain stimulation
protocols can also have differing effects across participants,
and these effects might be exacerbated when considering the
heterogeneity of neurodevelopmental disorders such as autism
spectrum disorder (ASD).
Another important factor to consider in trialing therapeutic
interventions is the optimal age of intervention. It might be
argued that the greatest effects will be seen if NIBS is applied
early in development, when the brain is considered more plastic.
As noted, however, there are important ethical and feasibility
concerns around NIBS in children. At present, a relatively
small number of typically developing children and children with
neurodevelopmental disorder have undergone NIBS. Single pulse
TMS has been applied to study development of corticospinal
projections in neonates within hours of birth (Eyre et al., 2001),
however, repetitive (rTMS) has been limited to older children
and adolescents. Thus, any interaction between repetitive brain
stimulation and neurodevelopment is currently unknown. This is
particularly important in the context of developmental disorders
where in most cases the developmental neuropathology has yet
to be fully elucidated.
In conclusion, there is an obvious need for further research
in this area. Specifically, studies focusing on developmental
trajectories and how the effects of NIBS change across childhood
would be extremely useful. The use of NIBS in children is a
burgeoning field whose full potential has yet to be realized. The
papers in this research topic speak to both the promise and the
challenges that researchers and clinicians face when applying
NIBS techniques to study typical development, developmental
pathophysiology, and as potential nonpharmacological, brain-
based treatments for neurodevelopmental disorders.
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